SFX by Ex Libris Inc.

Title:	Transthyretin amyloidosis: a tale of weak interactions
Source:	Febs Letters [0014-5793] Saraiva, Maria João Mascarenhas yr:2001

Basic

Full text

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Stoppini, M. "Systemic Amyloidosis: Lessons from Î²2-Microglobulin." Journal of biological chemistry 290.16 (2015): 9951-9958.
description	2.	Shortle, D. "Persistence of native-like topology in a denatured protein in 8 M urea." Science 293.5529 (2001): 487-9.
description	3.	Buxbaum, J N N. "The genetics of the amyloidoses." Annual review of medicine 51.1: 543-569.
description	4.	Liepnieks, Juris J J. "Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis." Amyloid 12.4 (2006): 170-7.
description	5.	Kohn, J. "Random-coil behavior and the dimensions of chemically unfolded proteins." Proceedings of the National Academy of Sciences of the United States of America 101.34 (2004): 12491-12496.
description	6.	Nubé, Menso J. J. Hemodiafiltration: Theory, Technology and Clinical Practice. Springer International Publishing :, 2016.
description	7.	Tan, S Y. "Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology." Kidney international 50.1 (1996): 282-9.
description	8.	Lachmann, Helen J. "Emerging treatments for amyloidosis." Kidney international 87.3 (2014): 516-26.
description	9.	Dong, J. "Unique Effect of Cu(II) in the Metal-Induced Amyloid Formation of Î²-2-Microglobulin." Biochemistry 53.8 (2014): 1263-1274.
description	10.	Munar-Qus, M. "Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin." Amyloid (2000): 266-269.
description	11.	Pepys, Mark B. "A molecular correlate of clinicopathology in transthyretin amyloidosis." The Journal of pathology 217.1 (2009): 1-3.
description	12.	Obici, L. "Proteomics in protein misfolding diseases." Clinical Chemistry and Laboratory Medicine 47.6 (2009): 627-635.
description	13.	Nakamura, M. "Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis." Neurology 65.7 (2005): 1051-6.
description	14.	Wang, Y. "A dynamic bundle of four adjacent hydrophobic segments in the denatured state of staphylococcal nuclease." Protein science 5.9 (1996): 1898-1906.
description	15.	Forman, Mark S S. "Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs." Nature medicine 10.10 (2004): 1055-1063.
description	16.	Zhang, Qinghai H. "Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: A likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice?" Biochemistry 44.25 (2005): 9079-9085.
description	17.	Almeida, M R R. "Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses." Current Drug Targets-CNS & Neurological Disorders 4.5: 587-596.
description	18.	Verchere, C B B. "Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes." Diabetes 48.2 (1999): 241-253.
description	19.	Shortle, D. "Characterization of long-range structure in the denatured state of staphylococcal nuclease. II. Distance restraints from paramagnetic relaxation and calculation of an ensemble of structures." Journal of molecular biology 268.1 (1997): 170-84.
description	20.	Rapezzi, C. "Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies?" Amyloid 13.3 (2006): 143-53.